Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. The Hunt for the Next 10 Bagger Message Board

$AMGN Recent News Facebook, Gilead shares fall

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 103157
Posted On: 11/01/2014 11:31:12 AM
Avatar
Posted By: Stock_Tracker
$AMGN Recent News

Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Amgen, under investor pressure, outlines strategy 10:05 a.m. Oct. 28, 2014 - MarketWatch.com
Amgen's stock rises after company outlines capital allocation plans 9:07 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen's stock climbs 3.2% in premarket trade after capital allocation plans 8:55 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 revenue $20.8 bln-$21.3 bln vs. FactSet consensus $20.33 bln 8:54 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 adj. EPS $9.05-$9.40 vs. FactSet consensus $9.08 8:53 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to payout 60% of adj. earnings to shareholders through 2018 8:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to raise dividend 30% starting in Q1 2015 8:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen resumes share buybacks, with plans for $2 bln in repurchases through 2015 8:51 a.m. Oct. 28, 2014 - Tomi Kilgore
‘Dumb money’ unloads bullish oil bets as prices pose threat to stocks 8:35 a.m. Oct. 28, 2014 - Shawn Langlois
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn
Newscast: Stocks mixed -- barely 6:46 p.m. Oct. 27, 2014 - MarketWatch
Twitter shares drop in wake of quarterly results 5:07 p.m. Oct. 27, 2014 - Sue Chang
Amgen posts strong results on higher sales 4:57 p.m. Oct. 27, 2014 - MarketWatch.com
Updates, advisories and surprises 4:31 p.m. Oct. 27, 2014 - MarketWatch
Amgen net drops, but adjusted earnings beat views 4:14 p.m. Oct. 27, 2014 - Russ Britt
Amgen GAAP net of $1.61 is below $1.81 view 4:06 p.m. Oct. 27, 2014 - Russ Britt
Amgen adj. net of $2.30 beats views of $2.11 4:05 p.m. Oct. 27, 2014 - Russ Britt
Amgen shares rise 1.9% following Q3 earnings release 4:04 p.m. Oct. 27, 2014 - Sue Chang
Amgen Q3 revenue is $5.03B vs. last year's $4.75B 4:04 p.m. Oct. 27, 2014 - Russ Britt


The Untouchables: Where Even Activist Investors Fear to Tread 2:58 p.m. Oct. 31, 2014 - TheStreet.com
AbbVie Beats Q3 Earnings Estimates, Raises Guidance 1:25 p.m. Oct. 31, 2014 - Investors Business Daily
Aegerion Q3 Loss Wider than Expected, 2014 View Lowered - Analyst Blog 11:32 a.m. Oct. 31, 2014 - Zacks.com
Amgen (AMGN) Hits New Lifetime High 9:47 a.m. Oct. 31, 2014 - TheStreet.com
United Therapeutics Sells Off On Good News - Why I Bought That Dip 3:52 p.m. Oct. 30, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: AIG, GS, AMGN 3:14 p.m. Oct. 30, 2014 - TheStreet.com
Amgen Continues To Offer The Best Value In Biotech 9:23 a.m. Oct. 30, 2014 - Seeking Alpha
Amgen: Great News Sends Shares To Fresh All-Time Highs 8:50 a.m. Oct. 30, 2014 - Seeking Alpha
Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings 8:21 a.m. Oct. 30, 2014 - 247WallSt.com
Buy These Top Ranked ETFs on Solid Biotech Stock Earnings - ETF News And Commentary 8:00 a.m. Oct. 30, 2014 - Zacks.com
10-Q: AMGEN INC 4:49 p.m. Oct. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Amgen Up on Strategic Initiatives and 2015 Guidance - Analyst Blog 3:05 p.m. Oct. 29, 2014 - Zacks.com
Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss - Analyst Blog 2:00 p.m. Oct. 29, 2014 - Zacks.com
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog 12:28 p.m. Oct. 29, 2014 - Zacks.com
3 Health Care Picks To Beat Earnings - Earnings ESP 12:09 p.m. Oct. 29, 2014 - Zacks.com
Ligand Pharmaceuticals Has Rich A Valuation Now But Is Undervalued For Long Term Success 11:34 a.m. Oct. 29, 2014 - Seeking Alpha
UPDATE: Nomura Upgrades Amgen 10:42 a.m. Oct. 29, 2014 - benzinga.com
Stock Market News for October 29, 2014 - Market News 10:10 a.m. Oct. 29, 2014 - Zacks.com
Analysts' Actions: Alibaba, Amazon.com, eBay, Cliffs Natural, More 8:50 a.m. Oct. 29, 2014 - TheStreet.com
Top Analyst Upgrades and Downgrades: Alibaba, Amgen, Cliffs, Michael Kors, Sanofi, Yahoo! and More 8:28 a.m. Oct. 29, 2014 - 247WallSt.com


Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire 9:15 a.m. Oct. 30, 2014 - PR Newswire - PRF
Xencor Renegotiates XmAb®5871 Agreement with Amgen; Regains All Rights and Plans Clinical Development in Rare Autoimmune Disease 4:00 p.m. Oct. 28, 2014 - PR Newswire - PRF
Amgen Outlines Strategy, Growth Objectives And Capital Allocation Plans 8:48 a.m. Oct. 28, 2014 - PR Newswire - PRF
Global and China Monoclonal Antibody Industry Report, 2014-2019 9:26 p.m. Oct. 27, 2014 - PR Newswire - PRF
Amgen's Third Quarter 2014 Revenues Increased 6 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 19 Percent To $2.30 4:01 p.m. Oct. 27, 2014 - PR Newswire - PRF
Amgen To Webcast 2014 Business Review Meeting On October 28 5:39 p.m. Oct. 23, 2014 - PR Newswire - PRF
Global Pediatric Drugs and Vaccines Market 5:08 p.m. Oct. 23, 2014 - PR Newswire - PRF
Amgen Announces Webcast of 2014 Third Quarter Financial Results 4:05 p.m. Oct. 23, 2014 - PR Newswire - PRF
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) 5:59 p.m. Oct. 22, 2014 - PR Newswire - PRF
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) 5:54 p.m. Oct. 22, 2014 - PR Newswire - PRF
Amgen Statement Regarding Third Point Investment 3:41 p.m. Oct. 21, 2014 - PR Newswire - PRF
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma 9:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 4:17 p.m. Oct. 17, 2014 - PR Newswire - PRF
Amgen Announces 2014 Fourth Quarter Dividend 4:03 p.m. Oct. 17, 2014 - PR Newswire - PRF
Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement 9:00 a.m. Oct. 17, 2014 - PR Newswire - PRF
Alirocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 6:40 p.m. Oct. 14, 2014 - PR Newswire - PRF
Welfare Initiatives, Clinical Data Presentation, Financing Plan, Regulatory Disclosure, and Positive Drug Trials - Research Reports on Johnson & Johnson, Merck, Medtronic, Covidien and Amgen 8:35 a.m. Oct. 13, 2014 - PR Newswire - PRF
Amgen's BiTE® Immunotherapy Blinatumomab Receives FDA Priority Review Designation In Acute Lymphoblastic Leukemia 4:05 p.m. Oct. 9, 2014 - PR Newswire - PRF
Amgen Announces Positive Top-Line Results From Phase 3 Study Evaluating The Efficacy And Safety Of Biosimilar Candidate ABP 501 Compared With Adalimumab In Patients With Moderate-To-Severe Plaque Psoriasis 9:15 a.m. Oct. 8, 2014 - PR Newswire - PRF



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us